Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD133 Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global CD133 Antibody Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Enzyme Linked Immunosorbent Assay
1.3.3 Immunocytochemistry
1.3.4 Immunohistochemistry
1.3.5 Western Blot
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD133 Antibody Market Perspective (2018-2029)
2.2 CD133 Antibody Growth Trends by Region
2.2.1 Global CD133 Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CD133 Antibody Historic Market Size by Region (2018-2024)
2.2.3 CD133 Antibody Forecasted Market Size by Region (2024-2029)
2.3 CD133 Antibody Market Dynamics
2.3.1 CD133 Antibody Industry Trends
2.3.2 CD133 Antibody Market Drivers
2.3.3 CD133 Antibody Market Challenges
2.3.4 CD133 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD133 Antibody Players by Revenue
3.1.1 Global Top CD133 Antibody Players by Revenue (2018-2024)
3.1.2 Global CD133 Antibody Revenue Market Share by Players (2018-2024)
3.2 Global CD133 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CD133 Antibody Revenue
3.4 Global CD133 Antibody Market Concentration Ratio
3.4.1 Global CD133 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD133 Antibody Revenue in 2022
3.5 CD133 Antibody Key Players Head office and Area Served
3.6 Key Players CD133 Antibody Product Solution and Service
3.7 Date of Enter into CD133 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CD133 Antibody Breakdown Data by Type
4.1 Global CD133 Antibody Historic Market Size by Type (2018-2024)
4.2 Global CD133 Antibody Forecasted Market Size by Type (2024-2029)
5 CD133 Antibody Breakdown Data by Application
5.1 Global CD133 Antibody Historic Market Size by Application (2018-2024)
5.2 Global CD133 Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CD133 Antibody Market Size (2018-2029)
6.2 North America CD133 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CD133 Antibody Market Size by Country (2018-2024)
6.4 North America CD133 Antibody Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD133 Antibody Market Size (2018-2029)
7.2 Europe CD133 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CD133 Antibody Market Size by Country (2018-2024)
7.4 Europe CD133 Antibody Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD133 Antibody Market Size (2018-2029)
8.2 Asia-Pacific CD133 Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CD133 Antibody Market Size by Region (2018-2024)
8.4 Asia-Pacific CD133 Antibody Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD133 Antibody Market Size (2018-2029)
9.2 Latin America CD133 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CD133 Antibody Market Size by Country (2018-2024)
9.4 Latin America CD133 Antibody Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD133 Antibody Market Size (2018-2029)
10.2 Middle East & Africa CD133 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CD133 Antibody Market Size by Country (2018-2024)
10.4 Middle East & Africa CD133 Antibody Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam CD133 Antibody Introduction
11.1.4 Abcam Revenue in CD133 Antibody Business (2018-2024)
11.1.5 Abcam Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD133 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD133 Antibody Business (2018-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Proteintech
11.3.1 Proteintech Company Detail
11.3.2 Proteintech Business Overview
11.3.3 Proteintech CD133 Antibody Introduction
11.3.4 Proteintech Revenue in CD133 Antibody Business (2018-2024)
11.3.5 Proteintech Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Detail
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology CD133 Antibody Introduction
11.4.4 Cell Signaling Technology Revenue in CD133 Antibody Business (2018-2024)
11.4.5 Cell Signaling Technology Recent Development
11.5 BioLegend
11.5.1 BioLegend Company Detail
11.5.2 BioLegend Business Overview
11.5.3 BioLegend CD133 Antibody Introduction
11.5.4 BioLegend Revenue in CD133 Antibody Business (2018-2024)
11.5.5 BioLegend Recent Development
11.6 Bioss
11.6.1 Bioss Company Detail
11.6.2 Bioss Business Overview
11.6.3 Bioss CD133 Antibody Introduction
11.6.4 Bioss Revenue in CD133 Antibody Business (2018-2024)
11.6.5 Bioss Recent Development
11.7 GeneTex
11.7.1 GeneTex Company Detail
11.7.2 GeneTex Business Overview
11.7.3 GeneTex CD133 Antibody Introduction
11.7.4 GeneTex Revenue in CD133 Antibody Business (2018-2024)
11.7.5 GeneTex Recent Development
11.8 HUABIO
11.8.1 HUABIO Company Detail
11.8.2 HUABIO Business Overview
11.8.3 HUABIO CD133 Antibody Introduction
11.8.4 HUABIO Revenue in CD133 Antibody Business (2018-2024)
11.8.5 HUABIO Recent Development
11.9 Miltenyi Biotec
11.9.1 Miltenyi Biotec Company Detail
11.9.2 Miltenyi Biotec Business Overview
11.9.3 Miltenyi Biotec CD133 Antibody Introduction
11.9.4 Miltenyi Biotec Revenue in CD133 Antibody Business (2018-2024)
11.9.5 Miltenyi Biotec Recent Development
11.10 NSJ Bioreagents
11.10.1 NSJ Bioreagents Company Detail
11.10.2 NSJ Bioreagents Business Overview
11.10.3 NSJ Bioreagents CD133 Antibody Introduction
11.10.4 NSJ Bioreagents Revenue in CD133 Antibody Business (2018-2024)
11.10.5 NSJ Bioreagents Recent Development
11.11 United States Biological
11.11.1 United States Biological Company Detail
11.11.2 United States Biological Business Overview
11.11.3 United States Biological CD133 Antibody Introduction
11.11.4 United States Biological Revenue in CD133 Antibody Business (2018-2024)
11.11.5 United States Biological Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Detail
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter CD133 Antibody Introduction
11.12.4 Beckman Coulter Revenue in CD133 Antibody Business (2018-2024)
11.12.5 Beckman Coulter Recent Development
11.13 Boster Biological Technology
11.13.1 Boster Biological Technology Company Detail
11.13.2 Boster Biological Technology Business Overview
11.13.3 Boster Biological Technology CD133 Antibody Introduction
11.13.4 Boster Biological Technology Revenue in CD133 Antibody Business (2018-2024)
11.13.5 Boster Biological Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CD133 Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global CD133 Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global CD133 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CD133 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CD133 Antibody Market Share by Region (2018-2024)
Table 8. Global CD133 Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CD133 Antibody Market Share by Region (2024-2029)
Table 10. CD133 Antibody Market Trends
Table 11. CD133 Antibody Market Drivers
Table 12. CD133 Antibody Market Challenges
Table 13. CD133 Antibody Market Restraints
Table 14. Global CD133 Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CD133 Antibody Market Share by Players (2018-2024)
Table 16. Global Top CD133 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD133 Antibody as of 2022)
Table 17. Ranking of Global Top CD133 Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by CD133 Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CD133 Antibody Product Solution and Service
Table 21. Date of Enter into CD133 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD133 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CD133 Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global CD133 Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CD133 Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global CD133 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CD133 Antibody Revenue Market Share by Application (2018-2024)
Table 29. Global CD133 Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CD133 Antibody Revenue Market Share by Application (2024-2029)
Table 31. North America CD133 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America CD133 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America CD133 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe CD133 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe CD133 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe CD133 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific CD133 Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific CD133 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific CD133 Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America CD133 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America CD133 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America CD133 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa CD133 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa CD133 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa CD133 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 46. Abcam Company Detail
Table 47. Abcam Business Overview
Table 48. Abcam CD133 Antibody Product
Table 49. Abcam Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 50. Abcam Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CD133 Antibody Product
Table 54. Thermo Fisher Scientific Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Proteintech Company Detail
Table 57. Proteintech Business Overview
Table 58. Proteintech CD133 Antibody Product
Table 59. Proteintech Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 60. Proteintech Recent Development
Table 61. Cell Signaling Technology Company Detail
Table 62. Cell Signaling Technology Business Overview
Table 63. Cell Signaling Technology CD133 Antibody Product
Table 64. Cell Signaling Technology Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 65. Cell Signaling Technology Recent Development
Table 66. BioLegend Company Detail
Table 67. BioLegend Business Overview
Table 68. BioLegend CD133 Antibody Product
Table 69. BioLegend Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 70. BioLegend Recent Development
Table 71. Bioss Company Detail
Table 72. Bioss Business Overview
Table 73. Bioss CD133 Antibody Product
Table 74. Bioss Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 75. Bioss Recent Development
Table 76. GeneTex Company Detail
Table 77. GeneTex Business Overview
Table 78. GeneTex CD133 Antibody Product
Table 79. GeneTex Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 80. GeneTex Recent Development
Table 81. HUABIO Company Detail
Table 82. HUABIO Business Overview
Table 83. HUABIO CD133 Antibody Product
Table 84. HUABIO Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 85. HUABIO Recent Development
Table 86. Miltenyi Biotec Company Detail
Table 87. Miltenyi Biotec Business Overview
Table 88. Miltenyi Biotec CD133 Antibody Product
Table 89. Miltenyi Biotec Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 90. Miltenyi Biotec Recent Development
Table 91. NSJ Bioreagents Company Detail
Table 92. NSJ Bioreagents Business Overview
Table 93. NSJ Bioreagents CD133 Antibody Product
Table 94. NSJ Bioreagents Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 95. NSJ Bioreagents Recent Development
Table 96. United States Biological Company Detail
Table 97. United States Biological Business Overview
Table 98. United States Biological CD133 Antibody Product
Table 99. United States Biological Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 100. United States Biological Recent Development
Table 101. Beckman Coulter Company Detail
Table 102. Beckman Coulter Business Overview
Table 103. Beckman Coulter CD133 Antibody Product
Table 104. Beckman Coulter Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 105. Beckman Coulter Recent Development
Table 106. Boster Biological Technology Company Detail
Table 107. Boster Biological Technology Business Overview
Table 108. Boster Biological Technology CD133 Antibody Product
Table 109. Boster Biological Technology Revenue in CD133 Antibody Business (2018-2024) & (US$ Million)
Table 110. Boster Biological Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD133 Antibody Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global CD133 Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global CD133 Antibody Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global CD133 Antibody Market Share by Application: 2022 VS 2029
Figure 7. Enzyme Linked Immunosorbent Assay Case Studies
Figure 8. Immunocytochemistry Case Studies
Figure 9. Immunohistochemistry Case Studies
Figure 10. Western Blot Case Studies
Figure 11. Others Case Studies
Figure 12. CD133 Antibody Report Years Considered
Figure 13. Global CD133 Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global CD133 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global CD133 Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global CD133 Antibody Market Share by Players in 2022
Figure 17. Global Top CD133 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD133 Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by CD133 Antibody Revenue in 2022
Figure 19. North America CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America CD133 Antibody Market Share by Country (2018-2029)
Figure 21. United States CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe CD133 Antibody Market Share by Country (2018-2029)
Figure 25. Germany CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific CD133 Antibody Market Share by Region (2018-2029)
Figure 33. China CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America CD133 Antibody Market Share by Country (2018-2029)
Figure 41. Mexico CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa CD133 Antibody Market Share by Country (2018-2029)
Figure 45. Turkey CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia CD133 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Abcam Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 49. Proteintech Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 50. Cell Signaling Technology Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 51. BioLegend Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 52. Bioss Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 53. GeneTex Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 54. HUABIO Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 55. Miltenyi Biotec Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 56. NSJ Bioreagents Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 57. United States Biological Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 58. Beckman Coulter Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 59. Boster Biological Technology Revenue Growth Rate in CD133 Antibody Business (2018-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed